Business Wire

NeuroInDx, Inc. Launches UNIPICK+™ – Adding New Capabilities to the Universal Single Cell Collection and Tissue Microdissection Instrument

Jaa

NeuroInDx, Inc. (NDX) is proud to announce the release of the latest version of the NDX Cell & Tissue Acquisition System, UNIPICK+™.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180612005054/en/

Automated UNIPICK+™ directly integrated with Olympus IX73 inverted microscope (Photo: Business Wire)

Automated UNIPICK+™ directly integrated with Olympus IX73 inverted microscope (Photo: Business Wire)

UNIPICK+™ is the latest member of the Cell & Tissue Acquisition System (CTAS) family of products built on patented capillary-based vacuum assisted technology conceived at UCLA and developed by NDX for the isolation of individual cells from cultures and tissue microdissection. The system uses a proprietary straddle to fit most commercially available inverted microscopes, allowing researchers to add single cell isolation capabilities to their lab bench at a fraction of the price of conventional systems.

The instrument can isolate cells from a variety of formats, including tissue sections, adherent cultures, cell suspensions, 3D cultures, smears, and microfluidic chips. UNIPICK+™ features new design, full digital control, and an optional automation. Among the new applications is a novel single cell adhesion assay for comparative measurements of binding strengths among various cell types or substrates. This capability expands UNIPICK+™ application from sample acquisition to single cell analysis.

UNIPICK+™ brings new automated features while remaining the simplest and most cost-efficient solution for single cell isolation and tissue microdissection. It is available as a free-standing unit that may be used with most inverted microscopes or may be directly integrated with Olympus IX73/83 microscopes. Researchers can simply use UNIPICK+™ when they need to isolate cells and then revert to their microscope for routine cell and tissue work. It only takes a few minutes to set up the system and no microscope modifications are required.

“UNIPICK+™ enhances our product line of the most versatile and cost-efficient tools for cell isolation and tissue microdissection. By designing our instruments to be compatible with common inverted microscopes, we continue to bring value added products at a fraction of the cost of other more expensive systems,” said Stan Karsten, PhD, NDX President and CEO.

About NeuroInDx, Inc.

NeuroInDx, Inc. (NDX), founded in 2006, develops instruments for cell collection and tissue microdissection for a wide range of applications in biological sciences. For more information, please visit www.NeuroInDx.com.

Contact information

NeuroInDx, Inc.
Stan Karsten, PhD, 424-731-7512
President and CEO
info@neuroindx.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

CONQUEST Completes the Financing of Its Sustainable Infrastructure Portfolio24.9.2018 13:18Tiedote

CONQUEST Asset Management (“CONQUEST”) announced it completed, on behalf of the Sustainable Infrastructure fund it manages, the financing of its solar photovoltaic assets portfolio. The transaction was closed with a major financial institution following a competitive selection process. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180924005404/en/ Photo Credit: Istock Prior to this transaction, CONQUEST had increased the size of its assets under management to circa 70MW as a result of 3 transactions closed in less than a year. This portfolio, located in the South of France, benefits from up to 20-year secured and inflation linked power purchase agreements from local incumbent utility EDF. “The financing market remains competitive across Western Europe for sustainable infrastructure. We are pleased with the outcome of this process and the quality of the project finance lenders and teams we managed to attract, which confirmed

L&T Technology Services (LTTS) wins USD 40 million Engineering Content Management (ECM) Deal in Europe24.9.2018 11:20Tiedote

L&T Technology Services Limited (NSE: LTTS), a leading global pure-play engineering services company, today announced that it has won a multi-year deal to provide digital content management services to a leading technology company’s industrial products segment. The deal is expected to run for a period of 5 years with an aggregate revenue potential of USD 40 million, covering Engineering Content Management (ECM) programs in the US and European regions. LTTS will leverage centers in Europe, US & India while assuming complete ownership and talent to manage content for all current and future product suites for the customer. This would include technical design specifications, diagnostic solutions for service engineers and product training for customers & engineers, thereby supporting the entire ECM cycle from product conceptualization to developing digital content platforms. “With engineering content becoming one of the cornerstones of digital transformation, this deal win highlights LTTS’

Prima Solutions Expands Product Offering and Geographical Reach Through the Acquisition of ICOD Inc.24.9.2018 11:00Tiedote

As part of its continuing growth strategy, Prima Solutions (Prima), the premier software platform for Property and Casualty insurers, has agreed to acquire ICOD Inc. (ICOD), the Canadian provider of software solutions for Life and Health insurance. Recognized as an established leader with its SN Assurance suite, ICOD offers a best-in class solution deliverable in SaaS or on premise. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180924005019/en/ The transaction, which closed on September 20th, accelerates Prima’s expansion into the Life and Health insurance market which is still largely using legacy technologies. The ICOD acquisition offers many synergies including: complementing Prima’s existing product offering, diversifying its customer base and expanding the platform for rapid growth in both Europe and North America. Hugues Delannoy, Chairman of Prima Solutions, said: "This acquisition provides a unique opportunity to ac

GE Renewable Energy Launches Cypress Onshore Wind Platform, Designed to Grow, Adapt, Thrive and Lower the Cost of Electricity for Customers24.9.2018 10:00Tiedote

GE Renewable Energy (NYSE:GE) today launched its new onshore turbine platform, named Cypress, and the next model from that platform, GE’s 5.3-158 turbine. The platform advances the proven technology of GE’s 2MW and 3MW fleets, which serves an installed base of nearly 20GW, while also utilizing architecture and innovations from the 4.8-158 turbine introduced in 2017. Cypress enables significant AEP improvements, increased efficiency in serviceability, improved logistics and siting potential, and ultimately more value for customers. It is designed to scale over time, enabling GE to offer a wider array of power ratings and hub heights to meet customer needs throughout the 5MW range. The platform also offers up to a 50 percent increase in AEP over the life of the platform versus GE’s 3MW turbines. It is the second major technology platform launch of the year for GE, which introduced the Haliade-X offshore turbine platform in March. This press release features multimedia. View the full rele

MarketSight Now Available in Six Languages24.9.2018 09:30Tiedote

MarketSight, LLC, a leading provider of data analysis and visualization solutions, has just introduced its award-winning solution in several new languages in its version 11.0 release. Originally available only in English, MarketSight is now being offered in French, German, Italian, Portuguese, and Spanish. MarketSight has always offered support for data in any language. With this new release, it becomes one of the only data analysis and visualization platforms for researchers offered with multiple language options. In addition to making MarketSight accessible to new users whose first language is not English, this new release also gives multilingual teams the ability to collaborate much more efficiently. Market research teams, consulting firms, and other global enterprises working in different languages can work on projects simultaneously while using MarketSight in the language they are most comfortable with. They can also share important findings with international clients through the

Cytox Expands Collaboration with AIBL to Identify Those Most at Risk to Rapidly Progress to Alzheimer’s24.9.2018 08:00Tiedote

Cytox, a precision medicine company which today is commercializing polygenic risk scoring (PRS) approaches for assessing genetic risk for developing Alzheimer’s disease (AD) and other neurological diseases, has announced it has expanded its research collaboration with the Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing (AIBL) to test new algorithms for identifying the pre-symptomatic and mild cognitively impaired people most at risk to progress to AD. Under the expanded agreement Cytox will assess genetic risk for accelerated development of AD using its current, commercially available, research use only approaches developed to run on the Thermo Fisher Scientific Applied Biosystems™ GeneTitan™ Multi-Channel (MC) instrument platform. AIBL will provide biobank samples together with associated longitudinal data from study research participants clinically diagnosed as cognitively normal, with mild cognitive impairment or with AD. Each subject has confirmed amyloid status

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme